CRS Report Lists Policy Options for Increasing Physician Training Education in Proper Opioid Prescribing

The Congressional Research Service (CRS) recently published a short “insight” report, Policy Options to Increase Physician Training Education in Proper Opioid Prescribing.  It responds to the recommendation of the President's Commission on Combating Drug Addiction and the Opioid Crisis to mandate "medical education and prescriber education initiatives in proper opioid prescribing and risks of developing an SUD [Substance Use Disorder]."

Video: Considering Health Equity from the Perspective of Occupational Health

David Michaels is keenly interested in the relationships between income, wealth, and equality with public health.  Until a year ago, Michaels served as the U.S. Assistant Secretary of Labor for Occupational Safety and Health.  Now a member of the Milken Institute School of Public Health faculty, Michaels discusses the importance of workplace safety and the current state of public health in a new video.

Study Shows Gender Differences in the Use of Parks in High-Poverty Neighborhoods

Study in the journal Women’s Health Issues suggests addressing safety concerns might get more women to use public parks

Two Women’s Health Issues Manuscripts Share Gibbs Leadership Prize

The Editorial Board of Women's Health Issues recently announced that the Charles E. Gibbs Leadership Prize for the best papers published in Women's Health Issues in 2017 was awarded to two authors: Soumitra S. Bhuyan, PhD, MPH, an Assistant Professor in the Division of Health Systems Management and Policy at the University of Memphis School of Public Health, and Maeve Ellen Wallace, PhD, a Research Assistant Professor in the Department of Global Community Health and Behavioral Sciences at Tulane University School of Public Health and Tropical Medicine.

Why FDA Should Implement Some of the National Academies’ Recommendations for Making Medicines Affordable

As the National Academies of Sciences, Engineering, and Medicine points out in a recent report, Making Medicines Affordable: A National Imperative, the U.S. biopharmaceutical sector has been successful in developing and delivering effective drugs for improving health and fighting disease over the past decades.  Many medical conditions that were long deemed untreatable can now be cured or managed effectively.